Tuesday, March 03, 2020 7:36:52 AM
@HindenburgRes
PharmaCielo's response this morning is wholly inadequate and addresses none of the issues we raised, nor does it offer any refutation of the specifics of our report. $PCLO $PCLOF's press release simply declares everything in our report to be false.
We pointed out that a CURRENT director (and original co-founder) misrepresented a bankruptcy & engaged in what appears to be brazen self-enrichment scheme with $PCLO $PCLOF's CURRENT largest shareholder. The company simply re-iterates its bull thesis (which we also debunked).
Shareholders would have been better served by $PCLO $PCLOF commenting on the Cauca greenhouse that doesn't exist, the fact that partner General Extract belongs to a former $PCLO COO, partner XPhyto's CEO's history of failed companies, or plans to deal with cash burn.
As far as $PCLO $PCLOF's vague legal threat at the end of its response, we would encourage the company to publicly detail any and all facts and/or specifics rebutting our research. But we think the public will be waiting a long time for that response, too.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM